Recent Blog Articles

Taking up adaptive sports

Cutting and self-harm: Why it happens and what to do

Discrimination at work is linked to high blood pressure

Pouring from an empty cup? Three ways to refill emotionally

Give praise to the elbow: A bending, twisting marvel

Sneezy and dopey? Seasonal allergies and your brain

The FDA relaxes restrictions on blood donation

Apps to accelerometers: Can technology improve mental health in older adults?

Swimming and skin: What to know if a child has eczema

A muscle-building obsession in boys: What to know and do

Guru P. Sonpavde, MD
Contributor
Guru P. Sonpavde, MD is the director of the bladder cancer program at Dana-Farber Cancer Institute and is on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus is on clinical trials to develop new drugs and combinations to treat urologic cancers, particularly bladder cancer. He also has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. He is a member of the Genitourinary Committee of Southwest Oncology Group and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee.
Posts by Guru P. Sonpavde, MD

Guru P. Sonpavde, MD
Cancer treatment: Is a clinical trial right for you?

Treatments